|
POLH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.649200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.838200E-01 |
| Normal-vs-Stage2 |
3.427600E-01 |
| Normal-vs-Stage3 |
5.351400E-01 |
| Normal-vs-Stage4 |
1.558380E-01 |
| Stage1-vs-Stage2 |
2.931400E-01 |
| Stage1-vs-Stage3 |
3.895400E-01 |
| Stage1-vs-Stage4 |
6.483800E-02 |
| Stage2-vs-Stage3 |
6.933200E-01 |
| Stage2-vs-Stage4 |
6.779800E-01 |
| Stage3-vs-Stage4 |
3.988600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.160800E-01 |
| Normal-vs-AfricanAmerican |
5.842600E-01 |
| Normal-vs-Asian |
6.178200E-01 |
| Caucasian-vs-AfricanAmerican |
4.449400E-01 |
| Caucasian-vs-Asian |
6.920800E-01 |
| AfricanAmerican-vs-Asian |
3.787200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.230200E-01 |
| Normal-vs-Female |
7.406000E-01 |
| Male-vs-Female |
6.465000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.755200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.467000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.401250E-01 |
| Normal-vs-Age(81-100Yrs) |
2.689600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.430300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.077890E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.201800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.787000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.812400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.232400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.047400E-01 |
| Classical-VS-Follicular |
3.558000E-04 |
| Classical-VS-Other |
2.891000E-01 |
| Classical-VS-Normal |
5.902000E-01 |
| Tall-VS-Follicular |
1.391990E-01 |
| Tall-VS-Other |
4.509800E-01 |
| Tall-VS-Normal |
7.125600E-01 |
| Follicular-VS-Other |
8.970000E-01 |
| Follicular-VS-Normal |
3.394200E-02 |
| Other-VS-Normal |
3.828400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.677400E-01 |
| Normal-vs-N1 |
5.396000E-01 |
| N0-vs-N1 |
7.859400E-01 |
|
|
